Full Breakdown
Suspicious Letters Sent to Colorado Democratic Lawmakers Prompt Federal Investigation
By Drooid · · How we work
Incident Overview
On Monday, letters containing unknown or white powder-like substances were delivered to the Denver offices of U.S. Rep. Diana DeGette, Rep. Jason Crow, Rep. Brittany Pettersen, and House Assistant Minority Leader Joe Neguse, as well as to the Denver office of U.S. Sen. John Hickenlooper. A similar envelope addressed to Sen. Michael Bennet’s office was intercepted before delivery. The letters arrived amid a broader pattern of suspicious mailings reported in Nebraska, Minnesota, Arizona, Mississippi, Oregon, and other states. Colorado Secretary of State Jena Griswold’s office reported no comparable incidents.
Federal Investigation
The FBI and the U.S. Postal Inspection Service have opened a joint inquiry. The FBI confirmed it is investigating a “series of suspicious mailings” sent to offices nationwide and is working to identify the individuals responsible, while declining to confirm details of any specific case. Postal investigators have taken the envelope received by Rep. Pettersen’s office for testing.
Officials’ Responses
All affected offices reported that staff members were unharmed and remain operational. Rep. DeGette emphasized the safety of her team, and Rep. Crow noted that his office continues to serve constituents. Sen. Hickenlooper’s office confirmed receipt of the letter but gave no further comment. Rep.
Verbatim Quotes
- “The nature of this mailing, and others like it being received by elected officials across the country, whether to cause physical harm or provoke unease among public servants, will not prevent me and my team from working day in and day out to serve the people of Colorado’s 2nd District,” — Minority Leader Joe Neguse
- “This is a deeply disturbing effort to intimidate sitting Members of Congress,” — S. Rep. Brittany Pettersen
Impact and Outlook
The incidents have heightened concerns about the safety of elected officials and prompted heightened security measures at congressional offices. Federal agencies continue to test the substances and trace their origins, with no public timeline for concluding the investigation.
